Lexaria Bioscience Corp. (LEXX) › Capital ExpendituresLexaria Bioscience Corp. (LEXX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2015: $02016: $3.1K2017: $02019: $646.2K2020: $02022: $49.2K2023: $33.7K2024: $43.0K2025: $24.6K$24.6K2015Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$24.6K-42.7%2024$43.0K+27.5%2023$33.7K-31.4%2022$49.2K—2020$0-100.0%2019$646.2K—2017$0-100.0%2016$3.1K—2015$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share